Benandi K, Spires A, Hansen A, Linfante A, et al. Systemic risk profiles of topical ruxolitinib and oral Janus kinase inhibitors in patients with atopic dermatitis: A retrospective cohort study from the TriNetX network. J Am Acad Dermatol 2025 Aug 12:S0190-9622(25)02388.
PMID: 40794004